Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C275070-10mg | 10mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $77.90 | |
C275070-50mg | 50mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $122.90 | |
C275070-100mg | 100mg | In stock | $195.90 | |
C275070-250mg | 250mg | In stock | $441.90 |
5-HT 4 receptor agonist. hERG blocker.
Synonyms | cisapride|81098-60-4|Cisaprida|Cisapridum|Prepulsid|Kaudalit|Pridesia|(+-)-Cisapride|CHEBI:3720|R 51619|Propulsid|Acenalin|Risamol|UVL329170W|86718-70-9|Kinestase|cis-4-Amino-5-chloro-N-(1-(3-(p-fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-o-anisamide|CHE |
---|---|
Specifications & Purity | ≥99% |
Storage Temp | Store at -20°C |
Shipped In | Dry ice |
Grade | Moligand™ |
Action Type | AGONIST, CHANNEL BLOCKER |
Mechanism of action | Agonist of 5-HT 4 receptor;Agonist of 5-HT 7 receptor;Channel blocker of K v11.1 |
Product Description | Product Description: |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide |
---|---|
INCHI | InChI=1S/C23H29ClFN3O4/c1-30-21-13-19(26)18(24)12-17(21)23(29)27-20-8-10-28(14-22(20)31-2)9-3-11-32-16-6-4-15(25)5-7-16/h4-7,12-13,20,22H,3,8-11,14,26H2,1-2H3,(H,27,29)/t20-,22+/m1/s1 |
InChi Key | DCSUBABJRXZOMT-IRLDBZIGSA-N |
Canonical SMILES | COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F |
Isomeric SMILES | CO[C@H]1CN(CC[C@H]1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F |
PubChem CID | 6917698 |
Molecular Weight | 465.95 |
PubChem CID | 2769 |
---|---|
ChEBI | CHEBI:151790 |
Wikipedia | Cisapride |
ChEMBL Ligand | CHEMBL1729 |
DrugBank Ligand | DB00604 |
BindingDB Ligand | 50005836 |
CAS Registry No. | 81098-60-4 |
DrugCentral Ligand | 660 |
GPCRdb Ligand | cisapride |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
K2103559 | Certificate of Analysis | Jun 14, 2023 | C275070 |
K2103561 | Certificate of Analysis | Jun 14, 2023 | C275070 |
K2103790 | Certificate of Analysis | Jun 14, 2023 | C275070 |
K2103791 | Certificate of Analysis | Jun 14, 2023 | C275070 |
Solubility | Soluble in DMSO to 100 mM and in ethanol to 25 mM (with warming) |
---|
Pictogram(s) | GHS05 |
---|---|
Signal | Danger |
Hazard Statements | H318:Causes serious eye damage |
Precautionary Statements | P280:Wear protective gloves/protective clothing/eye protection/face protection. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P305+P354+P338:IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing. P317:Get emergency medical help. |